Shukra Pharmaceuticals Ltd.
| BSE: 524632 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE551C01028 |
| BSE 00:00 | 20 May | 57.00 |
0 (0.00%) |
OPEN
61.85 |
HIGH
61.85 |
LOW
57.00 |
| NSE 05:30 | 01 Jan | Shukra Pharmaceuticals Ltd |
| OPEN | 61.85 |
| PREVIOUS CLOSE | 57.00 |
| VOLUME | 210 |
| 52-Week high | 92.60 |
| 52-Week low | 47.00 |
| P/E | 132.56 |
| Mkt Cap.(Rs cr) | 9 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Shukra Pharmaceuticals Ltd. (SHUKRAPHARMA) - Peer Group
| COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
| Vista Pharma. | 7.09 | 4.11 | 26.09 | 0.11 | -0.63 | 0.00 | - |
| Concord Drugs | 28.70 | -1.03 | 25.08 | 13.44 | 0.42 | 1.93 | 14.87 |
| Panjon | 15.60 | 1.63 | 24.18 | 3.42 | 0.05 | 0.12 | 130.00 |
| Roopa Industries | 30.50 | 1.67 | 24.00 | 13.20 | 0.26 | 1.20 | 25.42 |
| Ortin Labs. | 25.70 | -1.34 | 20.89 | 13.16 | 0.44 | 1.06 | 24.25 |
| Phaarmasia | 28.50 | -5.00 | 19.47 | 3.87 | -0.73 | 0.00 | - |
| Ishita Drugs | 48.85 | 2.84 | 14.61 | 4.33 | 0.15 | 2.95 | 16.56 |
| Parmax Pharma | 37.55 | 0.00 | 14.04 | 2.89 | -0.52 | 0.00 | - |
| Pharmaids Pharma | 12.74 | -0.31 | 13.13 | 0.30 | 0.01 | 0.14 | 91.00 |
| Colinz Labs | 28.60 | -1.38 | 13.07 | 1.59 | 0.09 | 0.72 | 39.72 |
| Veerhealth Care | 11.50 | -4.72 | 7.97 | 2.65 | 0.17 | 0.07 | 164.29 |
| Welcure Drugs | 5.70 | -5.00 | 7.70 | 0.08 | 0.07 | 0.02 | 285.00 |
| Unjha Formul. | 9.89 | 4.99 | 4.43 | 4.21 | -0.06 | 0.56 | 17.66 |
| Beryl Drugs | 8.69 | -4.92 | 4.41 | 3.22 | -0.10 | 0.00 | - |
| Hind.Bio Science | 3.54 | -4.84 | 3.63 | 0.24 | 0.00 | 0.00 | - |
Quick Links for Shukra Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
